These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 18250264)
41. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Hsieh MJ; Liu HT; Wang CN; Huang HY; Lin Y; Ko YS; Wang JS; Chang VH; Pang JS J Mol Med (Berl); 2017 Mar; 95(3):323-333. PubMed ID: 27847966 [TBL] [Abstract][Full Text] [Related]
42. The therapeutic effect of vascular endothelial growth factor gene- or heme oxygenase-1 gene-modified endothelial progenitor cells on neovascularization of rat hindlimb ischemia model. Long J; Wang S; Zhang Y; Liu X; Zhang H; Wang S J Vasc Surg; 2013 Sep; 58(3):756-65.e2. PubMed ID: 23562340 [TBL] [Abstract][Full Text] [Related]
43. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Hershey JC; Baskin EP; Glass JD; Hartman HA; Gilberto DB; Rogers IT; Cook JJ Cardiovasc Res; 2001 Feb; 49(3):618-25. PubMed ID: 11166275 [TBL] [Abstract][Full Text] [Related]
44. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway. Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734 [TBL] [Abstract][Full Text] [Related]
45. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Takeshita S; Pu LQ; Stein LA; Sniderman AD; Bunting S; Ferrara N; Isner JM; Symes JF Circulation; 1994 Nov; 90(5 Pt 2):II228-34. PubMed ID: 7525111 [TBL] [Abstract][Full Text] [Related]
46. Development of a two-stage limb ischemia model to better simulate human peripheral artery disease. Krishna SM; Omer SM; Li J; Morton SK; Jose RJ; Golledge J Sci Rep; 2020 Feb; 10(1):3449. PubMed ID: 32103073 [TBL] [Abstract][Full Text] [Related]
47. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Nakamura Y; Patrushev N; Inomata H; Mehta D; Urao N; Kim HW; Razvi M; Kini V; Mahadev K; Goldstein BJ; McKinney R; Fukai T; Ushio-Fukai M Circ Res; 2008 May; 102(10):1182-91. PubMed ID: 18451337 [TBL] [Abstract][Full Text] [Related]
51. (13)N-ammonia PET as a measurement of hindlimb perfusion in a mouse model of peripheral artery occlusive disease. Peñuelas I; Aranguren XL; Abizanda G; Martí-Climent JM; Uriz M; Ecay M; Collantes M; Quincoces G; Richter JA; Prósper F J Nucl Med; 2007 Jul; 48(7):1216-23. PubMed ID: 17574988 [TBL] [Abstract][Full Text] [Related]
52. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371 [TBL] [Abstract][Full Text] [Related]
53. Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia. Kuwahara G; Nishinakamura H; Kojima D; Tashiro T; Kodama S J Vasc Surg; 2013 Apr; 57(4):1090-9. PubMed ID: 23219511 [TBL] [Abstract][Full Text] [Related]
54. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432 [TBL] [Abstract][Full Text] [Related]
55. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia. Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499 [TBL] [Abstract][Full Text] [Related]
56. Myoglobin over-expression attenuates angiogenic response in hindlimb ischemia in mice. Yang YG; Guan H; Liu CW; Li YJ Chin Med J (Engl); 2009 May; 122(9):1056-60. PubMed ID: 19493440 [TBL] [Abstract][Full Text] [Related]
57. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433 [TBL] [Abstract][Full Text] [Related]
58. Quantitative PET imaging of VEGF receptor expression. Chen K; Cai W; Li ZB; Wang H; Chen X Mol Imaging Biol; 2009; 11(1):15-22. PubMed ID: 18784964 [TBL] [Abstract][Full Text] [Related]